BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 3022920)

  • 21. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
    Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
    Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung.
    Stahel RA; O'Hara CJ; Mabry M; Waibel R; Sabbath K; Speak JA; Bernal SD
    Cancer Res; 1986 Apr; 46(4 Pt 2):2077-84. PubMed ID: 3004719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
    Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
    Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunohistochemical study of lung carcinomas using a monoclonal antibody which specifically reacts to basal cells.
    Maeda K; Sueishi K
    Mod Pathol; 1990 Jan; 3(1):43-8. PubMed ID: 2155419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
    Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
    J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential usefulness of monoclonal antibodies in the determination of histologic types of lung cancer in cytologic preparations.
    Koprowska I; Zipfel SA
    Acta Cytol; 1988; 32(5):675-9. PubMed ID: 2844047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3.
    Roa RA; Hruban RH; McKenzie P; Richtsmeier W
    Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry with monoclonal antibody B72.3 as an adjunct in the cytologic diagnosis of pancreatic carcinoma.
    Ness MJ; Pour PM; Tempero MA; Linder J
    Mod Pathol; 1988 Jul; 1(4):279-83. PubMed ID: 2467286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface expression of tumor-associated antigens in primary cultured human colonic epithelial cells from carcinomas, benign tumors, and normal tissues.
    Friedman E; Thor A; Hand PH; Schlom J
    Cancer Res; 1985 Nov; 45(11 Pt 2):5648-55. PubMed ID: 2413994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
    Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
    Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
    Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
    Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
    Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
    Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigens associated with human squamous cell lung carcinoma defined by murine monoclonal antibodies.
    Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
    Cancer Res; 1986 Jun; 46(6):2970-7. PubMed ID: 3009005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody.
    Zylstra S; Chen FA; Ghosh SK; Repasky EA; Rao U; Takita H; Bankert RB
    Cancer Res; 1986 Dec; 46(12 Pt 1):6446-51. PubMed ID: 3536080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis.
    Shitara K; Fujiwara K; Kusano A; Yamaguchi K; Yoshida H; Sato S; Hanai N
    Anticancer Res; 1992; 12(4):1121-9. PubMed ID: 1503402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.